Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Screening Test Use Up After ACA
From - Diagnostic Testing & Emerging Technologies
There was an uptick in preventive screening after enactment of the Affordable Care Act (ACA), yet cancer-screening rates in the United States remain below…
Blood Test Plus Clinical Characteristics May Improve CAD Diagnosis
...
Already a member? Log in here
ACA Credited With Increasing Screening Test Use
...
Already a member? Log in here
New Biomarkers May Enable Personalized Prostate Cancer Screening
...
Already a member? Log in here
Genomics May Predict Cancer Treatment Side Effects
...
Already a member? Log in here
Many Women Still Leery of 2012 Cervical Cancer Screening Guidelines
...
Already a member? Log in here
Survey Finds Soft Skills Sought in Hiring New Pathologists
...
Already a member? Log in here
Trump Budget Proposes Steep NIH Cuts, Hike to FDA User Fees
...
Already a member? Log in here
Testing Guidelines at a Glance
From - Diagnostic Testing & Emerging Technologies
Two recent testing guidelines were released that address carrier screenings for pregnant women and a rare disease lacking a…
NGS Clinically Useful for Pediatric Cancers
From - Diagnostic Testing & Emerging Technologies
The Precision in Pediatric Sequencing (PIPseq) Program at Columbia University Medical Center released data on its first…